Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.

Source:http://linkedlifedata.com/resource/pubmed/id/21221771

Download in:

View as

General Info

PMID
21221771